ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China · Delayed Price · Currency is CNY 8.32
-0.31 (-3.59%)
At close: Jun 2, 2026
ChemPartner PharmaTech Market Cap
ChemPartner PharmaTech has a market cap or net worth of 4.14 billion as of June 2, 2026. Its market cap has increased by 40.78% in one year.
Market Cap
4.14B
Enterprise Value
4.16B
Revenue
1.13B
Ranking
n/a
PE Ratio
308.90
Stock Price
8.32
Market Cap Chart
Since December 22, 2010, ChemPartner PharmaTech's market cap has increased from 2.12B to 4.14B, an increase of 95.38%. That is a compound annual growth rate of 4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 4.30B | -9.73% |
| Dec 31, 2025 | 4.76B | 49.45% |
| Dec 31, 2024 | 3.19B | -16.38% |
| Dec 29, 2023 | 3.81B | -26.51% |
| Dec 30, 2022 | 5.18B | -24.67% |
| Dec 31, 2021 | 6.88B | -6.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lifecome Biochemistry | 4.57B |
| Zhejiang Wecome Pharmaceutical Company | 4.53B |
| Jiangsu Bioperfectus Technologies | 4.47B |
| Assure Tech (Hangzhou) | 4.35B |
| Beijing Scitop Bio-tech | 4.27B |
| Wuhan Hvsen Biotechnology | 4.24B |
| Kexing Biopharm | 4.18B |
| Beijing Bohui Innovation Biotechnology Group | 4.16B |